KIF18B | kinesin family member 18B | 17q21.31 | 0.331 | 0.529 | 0
|
SPAG5 | sperm associated antigen 5 | 17q11.2 | 0.329 | 0.532 | 0
|
CDCA8 | cell division cycle associated 8 | 1p34.3 | 0.32 | 0.529 | 0
|
UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 19p13.3 | 0.315 | 0.471 | 0
|
ORC1 | origin recognition complex, subunit 1 | 1p32 | 0.313 | 0.497 | 0
|
KIF15 | kinesin family member 15 | 3p21.31 | 0.312 | 0.51 | 0
|
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 2q13 | 0.311 | 0.493 | 0
|
CENPF | centromere protein F, 350/400kDa | 1q41 | 0.31 | 0.532 | 0
|
NCAPH | non-SMC condensin I complex, subunit H | 2q11.2 | 0.31 | 0.485 | 0
|
EXO1 | exonuclease 1 | 1q43 | 0.306 | 0.483 | 0
|
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | 15q15 | 0.304 | 0.501 | 0
|
XRCC2 | X-ray repair complementing defective repair in Chinese hamster cells 2 | 7q36 | 0.304 | 0.466 | 0
|
MCM2 | minichromosome maintenance complex component 2 | 3q21 | 0.303 | 0.481 | 0
|
TICRR | TOPBP1-interacting checkpoint and replication regulator | 15q26.1 | 0.303 | 0.517 | 0
|
FAM72B | family with sequence similarity 72, member B | 1p12 | 0.302 | 0.468 | 0
|
BIRC5 | baculoviral IAP repeat containing 5 | 17q25.3 | 0.302 | 0.426 | 0
|
HCFC1 | host cell factor C1 | Xq28 | 0.299 | 0.426 | 0
|
CENPJ | centromere protein J | 13q12.12 | 0.297 | 0.458 | 0
|
FAM171A2 | family with sequence similarity 171, member A2 | 17q21.31 | 0.295 | 0.543 | 0
|
FBXO45 | F-box protein 45 | 3q29 | 0.293 | 0.472 | 0
|
TPX2 | TPX2, microtubule-associated | 20q11.2 | 0.292 | 0.451 | 0
|
ESPL1 | extra spindle pole bodies like 1, separase | 12q13.13 | 0.292 | 0.486 | 0
|
BLM | Bloom syndrome, RecQ helicase-like | 15q26.1 | 0.289 | 0.48 | 0
|
SEPT3 | septin 3 | 22q13.2 | 0.284 | 0.425 | 0
|
DBR1 | debranching RNA lariats 1 | 3q22.3 | 0.284 | 0.34 | 6.8e-13
|
SAPCD2 | suppressor APC domain containing 2 | 9q34.3 | 0.283 | 0.505 | 0
|
CIT | citron rho-interacting serine/threonine kinase | 12q24.23 | 0.282 | 0.477 | 0
|
RILP | Rab interacting lysosomal protein | 17p13.3 | 0.275 | -0.341 | 6.02e-13
|
EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 7q35-q36 | 0.274 | 0.543 | 0
|
GMFG | glia maturation factor, gamma | 19q13.2 | 0.274 | -0.416 | 0
|
CASP2 | caspase 2, apoptosis-related cysteine peptidase | 7q34-q35 | 0.274 | 0.47 | 0
|
BEND3 | BEN domain containing 3 | 6q21 | 0.272 | 0.461 | 0
|
MEX3B | mex-3 RNA binding family member B | 15q25.1 | 0.272 | 0.386 | 5.27e-18
|
VASH2 | vasohibin 2 | 1q23 | 0.268 | 0.307 | 1.15e-10
|
ORAI3 | ORAI calcium release-activated calcium modulator 3 | 16p11.2 | 0.265 | -0.36 | 1.96e-14
|
CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 17q12 | 0.263 | 0.473 | 0
|
KDM2B | lysine (K)-specific demethylase 2B | 12q24.31 | 0.263 | 0.43 | 0
|
DALRD3 | DALR anticodon binding domain containing 3 | 3p21.31 | 0.262 | -0.247 | 2.46e-07
|
SPAST | spastin | 2p24-p21 | 0.262 | 0.408 | 0
|
CCDC77 | coiled-coil domain containing 77 | 12p13.33 | 0.261 | 0.458 | 0
|
NONO | non-POU domain containing, octamer-binding | Xq13.1 | 0.261 | 0.427 | 0
|
TPT1 | tumor protein, translationally-controlled 1 | 13q14 | 0.259 | -0.395 | 0
|
SOX4 | SRY (sex determining region Y)-box 4 | 6p22.3 | 0.259 | 0.402 | 0
|
UBE2O | ubiquitin-conjugating enzyme E2O | 17q25.1 | 0.258 | 0.474 | 0
|
BATF | basic leucine zipper transcription factor, ATF-like | 14q24 | 0.258 | -0.24 | 5.44e-07
|
SBK1 | SH3 domain binding kinase 1 | 16p11.2 | 0.258 | 0.361 | 1.69e-14
|
GPC2 | glypican 2 | 7q22.1 | 0.257 | 0.384 | 4.86e-17
|
TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 | 1p36.32 | 0.257 | -0.338 | 9.82e-13
|
OTX1 | orthodenticle homeobox 1 | 2p15 | 0.257 | 0.406 | 0
|
CASC15 | cancer susceptibility candidate 15 (non-protein coding) | 6p22.3 | 0.257 | 0.325 | 7.11e-12
|
TMEM201 | transmembrane protein 201 | 1p36.22 | 0.256 | 0.485 | 0
|
AMER1 | APC membrane recruitment protein 1 | Xq11.1 | 0.256 | 0.332 | 2.71e-12
|
CFH | complement factor H | 1q32 | 0.256 | -0.438 | 0
|
TMSB15A | thymosin beta 15a | Xq21.33-q22.3 | 0.256 | 0.323 | 9.88e-12
|
MSI1 | musashi RNA-binding protein 1 | 12q24 | 0.255 | 0.372 | 1.98e-15
|
CCDC150 | coiled-coil domain containing 150 | 2q33.1 | 0.255 | 0.476 | 0
|
JADE3 | jade family PHD finger 3 | Xp11.3 | 0.255 | 0.393 | 0
|
C1orf109 | chromosome 1 open reading frame 109 | 1p34.3 | 0.255 | 0.383 | 7.8e-17
|
B4GALNT4 | beta-1,4-N-acetyl-galactosaminyl transferase 4 | 11p15.5 | 0.254 | 0.407 | 0
|
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 20q11.2 | 0.254 | 0.378 | 4.44e-16
|
SPOCD1 | SPOC domain containing 1 | 1p35.1 | 0.254 | -0.3 | 3.13e-10
|
DCUN1D1 | DCN1, defective in cullin neddylation 1, domain containing 1 | 3q26.3 | 0.251 | 0.238 | 7.28e-07
|
CTDSP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 | 2q35 | 0.25 | -0.338 | 1.03e-12
|
GPSM3 | G-protein signaling modulator 3 | 6p21.3 | 0.249 | -0.415 | 0
|
TEAD2 | TEA domain family member 2 | 19q13.3 | 0.249 | 0.331 | 3.01e-12
|
CDH24 | cadherin 24, type 2 | 14q11.2 | 0.249 | 0.464 | 0
|
NKAIN1 | Na+/K+ transporting ATPase interacting 1 | 1p35.2 | 0.249 | 0.352 | 8.62e-14
|
SH3TC1 | SH3 domain and tetratricopeptide repeats 1 | 4p16.1 | 0.248 | -0.325 | 7.55e-12
|
C16orf86 | chromosome 16 open reading frame 86 | 16q22.1 | 0.248 | -0.355 | 5.14e-14
|
RFFL | ring finger and FYVE-like domain containing E3 ubiquitin protein ligase | 17q12 | 0.248 | 0.237 | 7.47e-07
|
CD163 | CD163 molecule | 12p13 | 0.247 | -0.106 | 0.0293
|
C14orf28 | chromosome 14 open reading frame 28 | 14q21.2 | 0.247 | -0.386 | 1.13e-17
|
ARSA | arylsulfatase A | 22q13.33 | 0.245 | -0.262 | 4.18e-08
|
CPSF6 | cleavage and polyadenylation specific factor 6, 68kDa | 12q15 | 0.245 | 0.392 | 0
|
UBA7 | ubiquitin-like modifier activating enzyme 7 | 3p21 | 0.244 | -0.331 | 3.21e-12
|
CADM4 | cell adhesion molecule 4 | 19q13.32 | 0.244 | 0.386 | 1.16e-17
|
PSMB10 | proteasome subunit beta 10 | 16q22.1 | 0.243 | -0.263 | 3.93e-08
|
KIF1A | kinesin family member 1A | 2q37.2 | 0.243 | 0.182 | 0.000158
|
LSG1 | large 60S subunit nuclear export GTPase 1 | 3q29 | 0.242 | 0.441 | 0
|
H2BFXP | H2B histone family, member X, pseudogene | Xq22.2 | 0.242 | 0.191 | 7.52e-05
|
ARNT2 | aryl-hydrocarbon receptor nuclear translocator 2 | 15q25.1 | 0.241 | 0.186 | 0.000115
|
CBX8 | chromobox homolog 8 | 17q25.3 | 0.24 | 0.452 | 0
|
KIAA1549 | KIAA1549 | 7q34 | 0.24 | 0.34 | 7.04e-13
|
ACACA | acetyl-CoA carboxylase alpha | 17q12 | 0.24 | 0.23 | 1.67e-06
|
KIAA1841 | KIAA1841 | 2p15 | 0.24 | 0.45 | 0
|
TK2 | thymidine kinase 2, mitochondrial | 16q22-q23.1 | 0.239 | -0.429 | 0
|
CST3 | cystatin C | 20p11.2 | 0.238 | -0.347 | 2.16e-13
|
SQLE | squalene epoxidase | 8q24.1 | 0.238 | 0.31 | 7.48e-11
|
E2F3 | E2F transcription factor 3 | 6p22 | 0.237 | 0.321 | 1.34e-11
|
TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 12q14.3 | 0.237 | -0.309 | 8.72e-11
|
BCAS4 | breast carcinoma amplified sequence 4 | 20q13 | 0.236 | -0.3 | 3.09e-10
|
CDKAL1 | CDK5 regulatory subunit associated protein 1-like 1 | 6p22.2 | 0.235 | 0.297 | 4.35e-10
|
CASC3 | cancer susceptibility candidate 3 | 17q21.1 | 0.234 | 0.213 | 9.25e-06
|
VANGL2 | VANGL planar cell polarity protein 2 | 1q22-q23 | 0.233 | 0.165 | 0.000622
|
PDLIM1 | PDZ and LIM domain 1 | 10q23.1 | 0.233 | -0.351 | 1.13e-13
|
LCAT | lecithin-cholesterol acyltransferase | 16q22.1 | 0.233 | -0.214 | 8.36e-06
|
PRKX | protein kinase, X-linked | Xp22.3 | 0.232 | 0.424 | 0
|
SLC25A53 | solute carrier family 25, member 53 | Xq22.2 | 0.232 | 0.152 | 0.00162
|
DCTD | dCMP deaminase | 4q35.1 | 0.23 | -0.248 | 2.35e-07
|
TAPBP | TAP binding protein (tapasin) | 6p21.3 | 0.23 | -0.196 | 4.5e-05
|
ADD2 | adducin 2 (beta) | 2p13.3 | 0.23 | 0.206 | 1.79e-05
|
INPP5D | inositol polyphosphate-5-phosphatase D | 2q37.1 | 0.23 | -0.334 | 1.76e-12
|
SLC29A4 | solute carrier family 29 (equilibrative nucleoside transporter), member 4 | 7p22.2 | 0.228 | 0.317 | 2.76e-11
|
RCC2 | regulator of chromosome condensation 2 | 1p36.13 | 0.228 | 0.482 | 0
|
SMPD4 | sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) | 2q21.1 | 0.228 | 0.361 | 1.89e-14
|
APOBEC3B | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | 22q13.1-q13.2 | 0.228 | 0.272 | 1.32e-08
|
GTF3C5 | general transcription factor IIIC, polypeptide 5, 63kDa | 9q34.13 | 0.228 | 0.429 | 0
|
C8orf58 | chromosome 8 open reading frame 58 | 8p21.3 | 0.227 | -0.3 | 2.97e-10
|
DPYSL5 | dihydropyrimidinase-like 5 | 2p23.3 | 0.226 | 0.281 | 4.27e-09
|
JUNB | jun B proto-oncogene | 19p13.13 | 0.226 | -0.351 | 1.09e-13
|
FHL2 | four and a half LIM domains 2 | 2q12.2 | 0.226 | -0.33 | 3.36e-12
|
MAFG | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G | 17q25.3 | 0.226 | 0.239 | 6.5e-07
|
EPHB3 | EPH receptor B3 | 3q27.1 | 0.225 | 0.36 | 2.02e-14
|
ILF2 | interleukin enhancer binding factor 2 | 1q21.3 | 0.225 | 0.356 | 4.16e-14
|
LIMA1 | LIM domain and actin binding 1 | 12q13.12 | 0.225 | -0.288 | 1.51e-09
|
CCDC117 | coiled-coil domain containing 117 | 22q12.1 | 0.224 | 0.322 | 1.16e-11
|
SP100 | SP100 nuclear antigen | 2q37.1 | 0.223 | -0.348 | 1.94e-13
|
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 3p22 | 0.222 | -0.42 | 0
|
LITAF | lipopolysaccharide-induced TNF factor | 16p13.3-p12 | 0.222 | -0.278 | 6.07e-09
|
TUBD1 | tubulin, delta 1 | 17q23.1 | 0.221 | 0.328 | 4.78e-12
|
CLU | clusterin | 8p21-p12 | 0.221 | -0.325 | 7.94e-12
|
ZDHHC7 | zinc finger, DHHC-type containing 7 | 16q23.1 | 0.221 | -0.236 | 8.71e-07
|
SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 2p23.3 | 0.22 | 0.423 | 0
|
SH3BGRL | SH3 domain binding glutamate-rich protein like | Xq13.3 | 0.219 | -0.386 | 8.43e-18
|
ANKRD13B | ankyrin repeat domain 13B | 17q11.2 | 0.219 | 0.359 | 2.73e-14
|
AIF1L | allograft inflammatory factor 1-like | 9q34.13-q34.3 | 0.219 | 0.271 | 1.38e-08
|
HES6 | hes family bHLH transcription factor 6 | 2q37.3 | 0.218 | 0.355 | 4.96e-14
|
STARD7 | StAR-related lipid transfer (START) domain containing 7 | 2p11.1 | 0.218 | 0.328 | 5.07e-12
|
FAM222A | family with sequence similarity 222, member A | 12q24.11 | 0.217 | 0.338 | 9.27e-13
|
DERL2 | derlin 2 | 17p13.2 | 0.217 | -0.055 | 0.258
|
DNM1 | dynamin 1 | 9q34 | 0.216 | 0.242 | 4.64e-07
|
LYSMD2 | LysM, putative peptidoglycan-binding, domain containing 2 | 15q21.2 | 0.215 | -0.214 | 8.4e-06
|
CHID1 | chitinase domain containing 1 | 11p15.5 | 0.214 | -0.171 | 0.000388
|
PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 5p13.1 | 0.214 | -0.205 | 2.14e-05
|
RTKN2 | rhotekin 2 | 10q21.3 | 0.214 | 0.319 | 1.89e-11
|
SUCLG2 | succinate-CoA ligase, GDP-forming, beta subunit | 3p14.3 | 0.214 | -0.266 | 2.83e-08
|
TRAF7 | TNF receptor-associated factor 7, E3 ubiquitin protein ligase | 16p13.3 | 0.212 | 0.281 | 3.92e-09
|
FXR2 | fragile X mental retardation, autosomal homolog 2 | 17p13.3 | 0.212 | 0.142 | 0.0033
|
HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | 5p14-p13 | 0.212 | 0.338 | 1e-12
|
RIOK2 | RIO kinase 2 | 5q14 | 0.211 | -0.176 | 0.000265
|
PGD | phosphogluconate dehydrogenase | 1p36.22 | 0.211 | 0.429 | 0
|
PHGDH | phosphoglycerate dehydrogenase | 1p12 | 0.211 | 0.292 | 9.81e-10
|
DPEP2 | dipeptidase 2 | 16q22.1 | 0.211 | -0.25 | 1.9e-07
|
CDR2L | cerebellar degeneration-related protein 2-like | 17q25.1 | 0.21 | 0.279 | 4.92e-09
|
KIAA0513 | KIAA0513 | 16q24.1 | 0.209 | -0.303 | 1.93e-10
|
ARHGEF26 | Rho guanine nucleotide exchange factor (GEF) 26 | 3q25.2 | 0.209 | 0.207 | 1.73e-05
|
BAGE2 | B melanoma antigen family, member 2 | 21p11.2 | 0.209 | 0.195 | 5.28e-05
|
LOC440173 | | | 0.208 | 0.259 | 6.32e-08
|
AKAP7 | A kinase (PRKA) anchor protein 7 | 6q23.2 | 0.208 | -0.398 | 0
|
DRAM1 | DNA-damage regulated autophagy modulator 1 | 12q23.2 | 0.207 | -0.325 | 7.18e-12
|
USP36 | ubiquitin specific peptidase 36 | 17q25.3 | 0.206 | 0.173 | 0.000345
|
ABLIM3 | actin binding LIM protein family, member 3 | 5q33.1 | 0.205 | -0.316 | 3.11e-11
|
PPP2R2C | protein phosphatase 2, regulatory subunit B, gamma | 4p16.1 | 0.205 | 0.266 | 2.82e-08
|
SYNE1 | spectrin repeat containing, nuclear envelope 1 | 6q25.2 | 0.205 | -0.319 | 1.89e-11
|
NHSL1 | NHS-like 1 | 6q23.3 | 0.204 | 0.358 | 3.13e-14
|
C10orf82 | chromosome 10 open reading frame 82 | 10q26.12 | 0.204 | -0.059 | 0.224
|
MAN2B2 | mannosidase, alpha, class 2B, member 2 | 4p16.2 | 0.203 | -0.243 | 3.89e-07
|
ARL6IP5 | ADP-ribosylation factor-like 6 interacting protein 5 | 3p14 | 0.203 | -0.385 | 3.2e-17
|
PLEKHG5 | pleckstrin homology domain containing, family G (with RhoGef domain) member 5 | 1p36.31 | 0.203 | 0.151 | 0.00181
|
NAAA | N-acylethanolamine acid amidase | 4q21.1 | 0.203 | -0.128 | 0.00798
|
ZMAT4 | zinc finger, matrin-type 4 | 8p11.21 | 0.202 | 0.169 | 0.000477
|
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 17q21.32 | 0.201 | 0.323 | 9.91e-12
|
SPATA24 | spermatogenesis associated 24 | 5q31.2 | 0.201 | -0.153 | 0.00157
|
CCZ1B | CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated | 7p22.2 | 0.2 | 0.322 | 1.29e-11
|
CHRNA3 | cholinergic receptor, nicotinic, alpha 3 (neuronal) | 15q24 | 0.199 | 0.149 | 0.00206
|
MAP3K7CL | MAP3K7 C-terminal like | 21q22.3 | 0.199 | -0.265 | 3.12e-08
|
HRASLS | HRAS-like suppressor | 3q29 | 0.199 | 0.252 | 1.5e-07
|
PBX2 | pre-B-cell leukemia homeobox 2 | 6p21.32 | 0.199 | -0.31 | 7.32e-11
|
GPR39 | G protein-coupled receptor 39 | 2q21-q22 | 0.198 | -0.252 | 1.53e-07
|
GDF11 | growth differentiation factor 11 | 12q13.13 | 0.198 | 0.1 | 0.0381
|
PANX2 | pannexin 2 | 22q13.33 | 0.197 | 0.394 | 0
|
TMEM52 | transmembrane protein 52 | 1p36.33 | 0.197 | 0.376 | 7.02e-16
|
KCNE3 | potassium channel, voltage gated subfamily E regulatory beta subunit 3 | 11q13.4 | 0.196 | -0.182 | 0.000155
|
FLJ44635 | | | 0.196 | -0.371 | 2.48e-15
|
FABP4 | fatty acid binding protein 4, adipocyte | 8q21.13 | 0.196 | -0.328 | 4.66e-12
|
ZDHHC18 | zinc finger, DHHC-type containing 18 | 1p36.11 | 0.194 | 0.346 | 2.4e-13
|
MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 22q13.33 | 0.193 | 0.338 | 9.07e-13
|
ZIC2 | Zic family member 2 | 13q32 | 0.192 | 0.282 | 3.53e-09
|
CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 12p13.1-p12 | 0.19 | 0.075 | 0.122
|
HN1L | hematological and neurological expressed 1-like | 16p13.3 | 0.188 | 0.296 | 5.2e-10
|
SLC38A6 | solute carrier family 38, member 6 | 14q23.1 | 0.187 | -0.138 | 0.00442
|
C8orf31 | chromosome 8 open reading frame 31 | 8q24.3 | 0.185 | -0.132 | 0.00645
|
SYT7 | synaptotagmin VII | 11q12.2 | 0.185 | 0.311 | 6.18e-11
|
UBTF | upstream binding transcription factor, RNA polymerase I | 17q21.31 | 0.185 | 0.222 | 3.76e-06
|
CLUL1 | clusterin-like 1 (retinal) | 18p11.32 | 0.183 | 0.011 | 0.826
|
PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | 8q21.13 | 0.182 | -0.085 | 0.0811
|
KLK14 | kallikrein-related peptidase 14 | 19q13.3-q13.4 | 0.182 | 0.253 | 1.3e-07
|
BTD | biotinidase | 3p25 | 0.181 | -0.22 | 4.56e-06
|
DKK1 | dickkopf WNT signaling pathway inhibitor 1 | 10q11.2 | 0.181 | -0.22 | 4.74e-06
|
PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme | 4q24 | 0.18 | -0.209 | 1.45e-05
|
TMEM217 | transmembrane protein 217 | 6p21.31-p21.2 | 0.177 | -0.26 | 5.56e-08
|
ACTR8 | ARP8 actin-related protein 8 homolog (yeast) | 3p21.31 | 0.176 | -0.146 | 0.00245
|
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 1q23 | 0.175 | -0.095 | 0.0508
|
PLA2R1 | phospholipase A2 receptor 1, 180kDa | 2q23-q24 | 0.174 | -0.165 | 0.000624
|
C7orf73 | chromosome 7 open reading frame 73 | 7q33 | 0.165 | 0.337 | 1.13e-12
|
DKFZp434J0226 | | | 0.162 | 0.257 | 8.33e-08
|